MHMickel J. Hansen

Mickel J. Hansen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mickel J. Hansen has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    General Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes

    by Lucien N. Lameijer, Simon Budzak, Nadja A. Simeth, Mickel J. Hansen, Ben L. Feringa, Denis Jacquemin, Wiktor Szymanski

    Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.


  • Open Access

    General Principles for the Design of Visible‐Light‐Responsive Photoswitches: Tetra‐ortho‐Chloro‐Azobenzenes

    by Lucien N. Lameijer, Simon Budzak, Nadja A. Simeth, Mickel J. Hansen, Ben L. Feringa, Denis Jacquemin, Wiktor Szymanski

    Molecular photoswitches enable reversible external control of biological systems, nanomachines, and smart materials. Their development is driven by the need for low energy (green‐red‐NIR) light switching, to allow non‐invasive operation with deep tissue penetration. The lack of clear design principles for the adaptation and optimization of such systems limits further applications. Here we provide a design rulebook for tetra‐ortho‐chloroazobenzenes, an emerging class of visible‐light‐responsive photochromes, by elucidating the role that substituents play in defining their key characteristics: absorption spectra, band overlap, photoswitching efficiencies, and half‐lives of the unstable cis isomers. This is achieved through joint photochemical and theoretical analyses of a representative library of molecules featuring substituents of varying electronic nature. A set of guidelines is presented that enables tuning of properties to the desired application through informed photochrome engineering.


  • Direct and Versatile Synthesis of Red‐Shifted Azobenzenes

    by Mickel J. Hansen, Michael M. Lerch, Wiktor Szymanski, Ben L. Feringa

    A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.


  • Direct and Versatile Synthesis of Red‐Shifted Azobenzenes

    by Mickel J. Hansen, Michael M. Lerch, Wiktor Szymanski, Ben L. Feringa

    A straightforward synthesis of azobenzenes with bathochromically‐shifted absorption bands is presented. It employs an ortho‐lithiation of aromatic substrates, followed by a coupling reaction with aryldiazonium salts. The products are obtained with good to excellent yields after simple purification. Moreover, with the presented methodology, a structurally diverse panel of different azobenzenes, including unsymmetric tetra‐ortho‐substituted ones, can be readily obtained, which paves the way for future development of red‐light‐addressable azobenzene derivatives for in vivo application.


  • Neue Ziele für die Photopharmakologie

    by Michael M. Lerch, Mickel J. Hansen, Gooitzen M. van Dam, Wiktor Szymanski, Ben L. Feringa

    Das Feld der Photopharmakologie nutzt durch Licht schaltbare Moleküle, um Kontrolle über die Wirkung biologisch aktiver Verbindungen zu erlangen. Das Ziel ist es, die systemische Toxizität von Wirkstoffen wie auch die Herausbildung von Resistenzen zu vermindern und gleichzeitig eine extrem hohe Präzision in der Behandlung zu erreichen. Durch die Verwendung niedermolekularer Verbindungen stellt die Photopharmakologie eine valide Alternative zur Optogenetik dar. Wir präsentieren hier einen Überblick über die pharmakologischen Zielstrukturen in verschiedenen Organen sowie über Organsysteme im menschlichen Körper, die auf nicht‐invasive Weise angesteuert werden können. Wir diskutieren die Perspektiven einer selektiven Lichtzuführung zu diesen Organen sowie die spezifischen Anforderungen lichtaktivierbarer Wirkstoffe. Über anwendungsorientierte Aspekte hinaus sind wir bestrebt, die Wirkstofftauglichkeit (“druggability”) pharmazeutischer Zielstrukturen anhand aktueller Ergebnisse zu illustrieren. Ferner wollen wir aufzeigen, an welchen Stellen neue Ansätze erforscht werden müssen, damit die Umsetzung von “intelligentem” Moleküldesign in der Photopharmakologie zur klinischen Anwendung gelingt.


  • Top Cited Papers

    Emerging Targets in Photopharmacology

    by Michael M. Lerch, Mickel J. Hansen, Gooitzen M. van Dam, Wiktor Szymanski, Ben L. Feringa

    The field of photopharmacology uses molecular photoswitches to establish control over the action of bioactive molecules. It aims to reduce systemic drug toxicity and the emergence of resistance, while achieving unprecedented precision in treatment. By using small molecules, photopharmacology provides a viable alternative to optogenetics. We present here a critical overview of the different pharmacological targets in various organs and a survey of organ systems in the human body that can be addressed in a non‐invasive manner. We discuss the prospects for the selective delivery of light to these organs and the specific requirements for light‐activatable drugs. We also aim to illustrate the druggability of medicinal targets with recent findings and emphasize where conceptually new approaches have to be explored to provide photopharmacology with future opportunities to bring “smart” molecular design ultimately to the realm of clinical use.


  • Open Access

    Cover Picture: Proteasome Inhibitors with Photocontrolled Activity (ChemBioChem 14/2014)

    by Mickel J. Hansen, Willem A. Velema, Gerjan de Bruin, Herman S. Overkleeft, Wiktor Szymanski, Ben L. Feringa